ESSA PHARMA INC's ticker is EPIX and the CUSIP is 29668H708. A total of 81 filers reported holding ESSA PHARMA INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $10,566,000 | +25.1% | 744,058 | -29.5% | 0.64% | +68.1% |
| Q3 2021 | $8,449,000 | -80.9% | 1,056,067 | -31.9% | 0.38% | -80.3% |
| Q2 2021 | $44,331,000 | -26.2% | 1,551,680 | -25.0% | 1.92% | -9.1% |
| Q1 2021 | $60,102,000 | +166.0% | 2,068,907 | +9.2% | 2.11% | +109.5% |
| Q4 2020 | $22,594,000 | +115.9% | 1,893,907 | +24.9% | 1.01% | +66.6% |
| Q3 2020 | $10,466,000 | – | 1,516,865 | – | 0.60% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Soleus Capital Management, L.P. | 4,223,799 | $26,103,000 | 3.37% |
| MPM BioImpact LLC | 660,892 | $4,084,000 | 1.10% |
| BVF INC/IL | 3,695,629 | $22,839,000 | 0.91% |
| Omega Fund Management, LLC | 328,196 | $2,028,000 | 0.42% |
| Eventide Asset Management | 4,170,259 | $25,772,000 | 0.40% |
| Frazier Life Sciences Management, L.P. | 692,910 | $4,282,000 | 0.36% |
| Bellevue Group AG | 5,034,814 | $31,115,000 | 0.36% |
| RTW INVESTMENTS, LP | 2,637,192 | $16,298,000 | 0.34% |
| Avidity Partners Management LP | 2,460,000 | $15,203,000 | 0.32% |
| Rhenman & Partners Asset Management AB | 410,923 | $2,540,000 | 0.25% |